Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |